Myovant Sciences Ltd (MYOV) Forecast, Price Target & Analyst Ratings
NYSE:MYOV • BMG637AM1024
26.98 USD
-0.01 (-0.04%)
At close: Mar 9, 2023
26.98 USD
0 (0%)
After Hours: 3/9/2023, 8:04:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for Myovant Sciences Ltd (MYOV).
Forecast Snapshot
Consensus Price Target
$27.54
+ 2.08% Upside
Next Earnings Forecast
Release DateMay 8, 2023
PeriodQ4 / 2023
EPS Estimate-$0.52
Revenue Estimate107.87M
ChartMill Buy Consensus
76.00%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
$27.54
Upside
+ 2.08%
From current price of $26.98 to mean target of $27.54, Based on 10 analyst forecasts
Low
$27.27
Median
$27.54
High
$28.35
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
10 Wall Street analysts provided a forecast for the next 12 months for MYOV. The average price target is 27.54 USD. This implies a price increase of 2.08% is expected in the next year compared to the current price of 26.98.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
76.00%
MYOV was analyzed by 10 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about MYOV.
In the previous month the buy percentage consensus was at a similar level.
MYOV was analyzed by 10 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2022-10-26 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2022-10-25 | SVB Leerink | Downgrade | Outperform -> Market Perform |
| 2022-10-24 | Baird | Downgrade | Outperform -> Neutral |
| 2022-08-09 | SVB Leerink | Upgrade | Market Perform -> Outperform |
| 2022-07-28 | Goldman Sachs | Maintains | Neutral |
| 2022-05-11 | Goldman Sachs | Maintains | Neutral |
| 2022-04-13 | SVB Leerink | Maintains | Market Perform |
| 2022-02-16 | SVB Leerink | Maintains | Market Perform |
| 2022-01-05 | SVB Leerink | Maintains | Market Perform |
| 2021-10-27 | SVB Leerink | Maintains | Market Perform |
| 2021-09-09 | SVB Leerink | Initiate | Market Perform |
| 2021-02-12 | SVB Leerink | Maintains | Market Perform |
Next Earnings Forecast Details
Next Earnings Details
Release DateMay 8, 2023
PeriodQ4 / 2023
EPS Estimate-$0.52
Revenue Estimate107.87M
Revenue Q2Q87.38%
EPS Q2Q17.83%
Number of Analysts6
Next Earnings Revisions
Revenue (1 Month)
0.00%
Revenue (3 Months)
0.00%
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%
Next Earnings Summary
MYOV is expected to report earnings on 5/8/2023. The consensus EPS estimate for the next earnings is -0.52 USD and the consensus revenue estimate is 107.87M USD.
The next earnings revenue estimate has been revised downward by 0% in the past 3 months.
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 59.32M | 230.972M 289.37% | 427.93M 85.27% | 556.07M 29.94% | 701.44M 26.14% | 1.082B 54.25% | 1.524B 40.85% | 1.593B 4.53% | 1.704B 6.97% | ||
| EBITDA YoY % growth | -273.09M -3.27% | -258.28M 5.42% | -185.968M 28.00% | -100.104M 46.17% | -106.65M -6.54% | -81.471M 23.61% | 256.57M 414.92% | N/A | N/A | N/A | |
| EBIT YoY % growth | -274.89M -3.80% | -260.78M 5.13% | -187.346M 28.16% | -100.907M 46.14% | -43.936M 56.46% | 47.512M 208.14% | -2.142M -104.51% | 334.66M 15,723.72% | 247.96M -25.91% | 417.18M 68.24% | |
| Operating Margin | N/A | -439.62% | -81.11% | -23.58% | -7.90% | 6.77% | -0.20% | 21.96% | 15.57% | 24.48% | |
| EPS YoY % growth | -3.32 18.63% | -2.83 14.76% | -2.21 21.91% | -1.78 19.42% | -0.93 47.54% | -0.54 42.50% | 0.96 278.46% | 2.35 144.71% | 1.73 -26.09% | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| Q4 / 23 | Q1 / 24 | Q2 / 24 | Q3 / 24 | Q4 / 24 | |
|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.52 17.83% | -0.28 -26.73% | -0.36 22.96% | 0.07 111.24% | -0.20 60.59% |
| Revenue Q2Q % growth | 107.87M 87.38% | 126.26M 8.39% | 130.45M 24.45% | 185.3M 84.88% | 169.68M 57.30% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -32.985M 36.49% | -21.035M -124.71% | -35.589M -5.57% | 9.264M 117.85% | -19.132M 42.00% |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
20.67%
EPS Next 5 Year
25.08%
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
43.72%
Revenue Next 5 Year
45.18%
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
15.08%
EBIT Next 5 Year
36.76%
Myovant Sciences Ltd / MYOV Forecast FAQ
Can you provide the average price target for Myovant Sciences Ltd stock?
10 analysts have analysed MYOV and the average price target is 27.54 USD. This implies a price increase of 2.08% is expected in the next year compared to the current price of 26.98.
What is the next earnings date for MYOV stock?
Myovant Sciences Ltd (MYOV) will report earnings on 2023-05-08, after the market close.
Can you provide the consensus estimates for Myovant Sciences Ltd next earnings?
The consensus EPS estimate for the next earnings of Myovant Sciences Ltd (MYOV) is -0.52 USD and the consensus revenue estimate is 107.87M USD.
How do analysts rate Myovant Sciences Ltd (MYOV)?
The consensus rating for Myovant Sciences Ltd (MYOV) is 76 / 100 . This indicates that analysts generally have a positive outlook on the stock.